These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32887705)

  • 1. Impact of Quality Improvement (QI) Program on 5-Year Risk of Diabetes-Related Complications: A Simulation Study.
    Shao H; Fonseca V; Furman R; Meneghini L; Shi L
    Diabetes Care; 2020 Nov; 43(11):2847-2852. PubMed ID: 32887705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality improvement strategies for diabetes care: Effects on outcomes for adults living with diabetes.
    Konnyu KJ; Yogasingam S; Lépine J; Sullivan K; Alabousi M; Edwards A; Hillmer M; Karunananthan S; Lavis JN; Linklater S; Manns BJ; Moher D; Mortazhejri S; Nazarali S; Paprica PA; Ramsay T; Ryan PM; Sargious P; Shojania KG; Straus SE; Tonelli M; Tricco A; Vachon B; Yu CH; Zahradnik M; Trikalinos TA; Grimshaw JM; Ivers N
    Cochrane Database Syst Rev; 2023 May; 5(5):CD014513. PubMed ID: 37254718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes INSIDE: Improving Population HbA
    Furman RE; Harlan TS; LeBlanc L; Furman EC; Liptak G; Fonseca VA
    Diabetes Care; 2020 Feb; 43(2):329-336. PubMed ID: 31796573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of a Multicomponent Quality Improvement Strategy to Improve Achievement of Diabetes Care Goals: A Randomized, Controlled Trial.
    Ali MK; Singh K; Kondal D; Devarajan R; Patel SA; Shivashankar R; Ajay VS; Unnikrishnan AG; Menon VU; Varthakavi PK; Viswanathan V; Dharmalingam M; Bantwal G; Sahay RK; Masood MQ; Khadgawat R; Desai A; Sethi B; Prabhakaran D; Narayan KM; Tandon N;
    Ann Intern Med; 2016 Sep; 165(6):399-408. PubMed ID: 27398874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a multicomponent quality improvement strategy on sustained achievement of diabetes care goals and macrovascular and microvascular complications in South Asia at 6.5 years follow-up: Post hoc analyses of the CARRS randomized clinical trial.
    Ali MK; Singh K; Kondal D; Devarajan R; Patel SA; Menon VU; Varthakavi PK; Vishwanathan V; Dharmalingam M; Bantwal G; Sahay RK; Masood MQ; Khadgawat R; Desai A; Prabhakaran D; Narayan KMV; Tandon N
    PLoS Med; 2024 Jun; 21(6):e1004335. PubMed ID: 38829880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial.
    Ali MK; Chwastiak L; Poongothai S; Emmert-Fees KMF; Patel SA; Anjana RM; Sagar R; Shankar R; Sridhar GR; Kosuri M; Sosale AR; Sosale B; Rao D; Tandon N; Narayan KMV; Mohan V;
    JAMA; 2020 Aug; 324(7):651-662. PubMed ID: 32809002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New-onset diabetes in elderly subjects: association between HbA1c levels, mortality, and coronary revascularization.
    Twito O; Ahron E; Jaffe A; Afek S; Cohen E; Granek-Catarivas M; Klein P; Hermoni D
    Diabetes Care; 2013 Nov; 36(11):3425-9. PubMed ID: 23877985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study.
    de Ritter R; Sep SJS; van der Kallen CJH; Schram MT; Koster A; Kroon AA; van Greevenbroek MMJ; Eussen SJPM; Dagnelie PC; de Jong M; Vos RC; Woodward M; Bots ML; Peters SAE; Stehouwer CDA
    BMJ Open Diabetes Res Care; 2019; 7(1):e000787. PubMed ID: 31798903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in Saudi Arabia: an interventional parallel-group controlled study.
    Tourkmani AM; Abdelhay O; Alkhashan HI; Alaboud AF; Bakhit A; Elsaid T; Alawad A; Alobaikan A; Alqahtani H; Alqahtani A; Mishriky A; Bin Rsheed A; Alharbi TJ
    BMC Fam Pract; 2018 Jan; 19(1):1. PubMed ID: 29291706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes.
    Sharif S; van der Graaf Y; Nathoe HM; de Valk HW; Visseren FL; Westerink J;
    Diabetes Care; 2016 Aug; 39(8):1424-30. PubMed ID: 27222511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality in Individuals Aged 80 and Older with Type 2 Diabetes Mellitus in Relation to Glycosylated Hemoglobin, Blood Pressure, and Total Cholesterol.
    Hamada S; Gulliford MC
    J Am Geriatr Soc; 2016 Jul; 64(7):1425-31. PubMed ID: 27295278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis.
    Tricco AC; Ivers NM; Grimshaw JM; Moher D; Turner L; Galipeau J; Halperin I; Vachon B; Ramsay T; Manns B; Tonelli M; Shojania K
    Lancet; 2012 Jun; 379(9833):2252-61. PubMed ID: 22683130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term impact of HbA1c on morbidity and all-cause mortality in people with type 2 diabetes: a Danish population-based observational study.
    Skriver MV; Støvring H; Kristensen JK; Charles M; Sandbæk A
    Diabetologia; 2012 Sep; 55(9):2361-70. PubMed ID: 22736395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic importance of baseline and serial glycated hemoglobin levels in high-risk patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CR; Leite NC; Ferreira MT; Salles GF
    Acta Diabetol; 2015 Feb; 52(1):21-9. PubMed ID: 24816865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [AMD Annals: a model of continuous monitoring and improvement of the quality of diabetes care].
    Gruppo di studio ANNALI AMD
    Epidemiol Prev; 2011; 35(1):18-26. PubMed ID: 21436491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study).
    Laiteerapong N; Ham SA; Gao Y; Moffet HH; Liu JY; Huang ES; Karter AJ
    Diabetes Care; 2019 Mar; 42(3):416-426. PubMed ID: 30104301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considerably decreased risk of cardiovascular disease with combined reductions in HbA1c, blood pressure and blood lipids in type 2 diabetes: Report from the Swedish National Diabetes Register.
    Eeg-Olofsson K; Zethelius B; Gudbjörnsdottir S; Eliasson B; Svensson AM; Cederholm J
    Diab Vasc Dis Res; 2016 Jul; 13(4):268-77. PubMed ID: 27190080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world data on metabolic effects of PCSK9 inhibitors in a tertiary care center in patients with and without diabetes mellitus.
    Fischer LT; Hochfellner DA; Knoll L; Pöttler T; Mader JK; Aberer F
    Cardiovasc Diabetol; 2021 Apr; 20(1):89. PubMed ID: 33894772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling incremental benefits on complications rates when targeting lower HbA
    Mostafa SA; Coleman RL; Agbaje OF; Gray AM; Holman RR; Bethel MA
    Diabet Med; 2018 Jan; 35(1):72-77. PubMed ID: 29057545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in body mass index, glycosylated hemoglobin A1C, blood pressure, and LDL-cholesterol among type 2 diabetes patients in Malaysia: A population-based longitudinal study.
    Wan KS; Moy FM; Mustapha FI; Ismail M; Hairi NN
    J Diabetes; 2021 Nov; 13(11):915-929. PubMed ID: 34142456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.